A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis
Preprint in medRxiv (April 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Preprint in medRxiv (April 2024)
Article (July 2023)
Article in The Journal of Infectious Diseases (February 2023)